Literature DB >> 9567223

Interest in smoking cessation among methadone maintained outpatients.

D L Frosch1, S Shoptaw, M E Jarvik, R A Rawson, W Ling.   

Abstract

The prevalence of cigarette smoking among opiate abusers is extremely high and tobacco related diseases are a major factor associated with morbidity and mortality for this group. Yet, many treatment providers remain reluctant to address smoking cessation with their clients due in part to the belief that substance abusers are not interested in quitting smoking. The present study examined self-reported interest in smoking cessation among methadone maintenance clients (N = 120) in four clinics in Los Angeles. Fifty-eight percent of subjects rated themselves as 'Somewhat' or 'Very Interested' in a smoking cessation program. Overall subjects appeared to accurately perceive the personal risks from tobacco smoking. In conclusion we find that clients in methadone maintenance treatment programs evidence a high level of interest in quitting smoking and may well be suited for a highly structured smoking cessation intervention.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9567223     DOI: 10.1300/J069v17n02_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  18 in total

1.  How is tobacco treatment provided during drug treatment?

Authors:  Jamie J Hunt; A Paula Cupertino; Susan Garrett; Peter D Friedmann; Kimber P Richter
Journal:  J Subst Abuse Treat       Date:  2011-08-09

2.  Understanding the drug treatment community's ambivalence towards tobacco use and treatment.

Authors:  Kimber P Richter; Jamie J Hunt; A Paula Cupertino; Susan Garrett; Peter D Friedmann
Journal:  Int J Drug Policy       Date:  2012-01-26

3.  Smoking and opioid detoxification: behavioral changes and response to treatment.

Authors:  Paolo Mannelli; Li-Tzy Wu; Kathleen S Peindl; David A Gorelick
Journal:  Nicotine Tob Res       Date:  2013-04-09       Impact factor: 4.244

4.  A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).

Authors:  Sandra Nordmann; Caroline Lions; Antoine Vilotitch; Laurent Michel; Marion Mora; Bruno Spire; Gwenaelle Maradan; Alain Morel; Perrine Roux; M Patrizia Carrieri
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

5.  Commitment and capacity for providing evidence-based tobacco treatment in US drug treatment facilities.

Authors:  Kimber P Richter; Jamie J Hunt; A Paula Cupertino; Byron J Gajewski; Yu Jiang; Janet Marquis; Peter D Friedmann
Journal:  Subst Abus       Date:  2016-11-29       Impact factor: 3.716

6.  Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Stacey C Sigmon
Journal:  Exp Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.157

7.  Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement.

Authors:  Malcolm S Reid; Huiping Jiang; Bryan Fallon; Susan Sonne; Paul Rinaldi; Eva Turrigiano; Cynthia Arfken; James Robinson; John Rotrosen; Edward V Nunes
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

Review 8.  Current perspectives on smoking cessation among substance abusers.

Authors:  Maria A Sullivan; Lirio S Covey
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

9.  Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities.

Authors:  Erin A McClure; Shauna P Acquavita; Kelly E Dunn; Kenneth B Stoller; Maxine L Stitzer
Journal:  J Subst Abuse Treat       Date:  2013-08-27

10.  Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.

Authors:  Stacey C Sigmon; Mollie E Miller; Andrew C Meyer; Kathryn Saulsgiver; Gary J Badger; Sarah H Heil; Stephen T Higgins
Journal:  Addiction       Date:  2016-01-23       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.